4-acetamido-5-(2-(3,4-dihydroxybenzylidene)hydrazine-1-carbonyl)-N-(4-methoxyphenyl)-2-(phenylamino)thiophene-3-carboxamide

ID: ALA5268406

Chembl Id: CHEMBL5268406

Max Phase: Preclinical

Molecular Formula: C28H25N5O6S

Molecular Weight: 559.60

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(NC(=O)c2c(Nc3ccccc3)sc(C(=O)N/N=C/c3ccc(O)c(O)c3)c2NC(C)=O)cc1

Standard InChI:  InChI=1S/C28H25N5O6S/c1-16(34)30-24-23(26(37)31-19-9-11-20(39-2)12-10-19)28(32-18-6-4-3-5-7-18)40-25(24)27(38)33-29-15-17-8-13-21(35)22(36)14-17/h3-15,32,35-36H,1-2H3,(H,30,34)(H,31,37)(H,33,38)/b29-15+

Standard InChI Key:  MOTFKPFRGPPMMG-WKULSOCRSA-N

Alternative Forms

  1. Parent:

    ALA5268406

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin beta (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 559.60Molecular Weight (Monoisotopic): 559.1526AlogP: 4.89#Rotatable Bonds: 9
Polar Surface Area: 161.38Molecular Species: NEUTRALHBA: 9HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.92CX Basic pKa: 1.13CX LogP: 6.00CX LogD: 5.98
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.10Np Likeness Score: -1.11

References

1. Soltan OM, Shoman ME, Abdel-Aziz SA, Narumi A, Konno H, Abdel-Aziz M..  (2021)  Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.,  225  [PMID:34450497] [10.1016/j.ejmech.2021.113768]

Source